• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛患者在降钙素基因相关肽单克隆抗体预防开始时的发作间期负担。

Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention.

作者信息

Lampl Christian, Seng Elizabeth, Vincent Maurice, Lenderking William R, Hoyt Margaret, Hetherington Lucinda, Ladd Mary Kate, Malley Karen, Chen Jun, Viktrup Lars

机构信息

Department of Neurology, Konventhospital Barmherzige Brüder Linz, Linz, Austria.

Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

J Headache Pain. 2024 Dec 18;25(1):220. doi: 10.1186/s10194-024-01927-8.

DOI:10.1186/s10194-024-01927-8
PMID:39695402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11658275/
Abstract

BACKGROUND

The total burden of migraine includes not only the episodes with headache pain but extends throughout the interictal periods. Interictal symptoms and associated psychological responses may profoundly impact well-being and drive treatment-seeking behavior.

METHODS

A cross-sectional online survey was conducted with participants aged ≥ 18 years, 250 with episodic migraine (EM) and 250 with chronic migraine (CM), having ≥ 4 monthly migraine headache days. All were naïve to galcanezumab or began ≤ 6 months before survey completion. The study evaluated factors associated with the Migraine Interictal Burden Scale (MIBS-4), including social determinants of health and well-being. Multiple linear regression, logistic regression, and random forests (RF) were used to explore predictors of MIBS-4.

RESULTS

The majority of participants (90%) were female with a mean (standard deviation) age of 40.6 (± 12.0) years and 18.1 (± 12.7) years since the first migraine episode. Sociodemographically, the EM and CM groups were similar. Common comorbidities were anxiety disorder (45%) and depression (44%). Migraine family history was reported in 59% of participants. MIBS-4 was correlated with a number of diverse variables, including well-being, anxiety sensitivity, income, aura symptoms, and the worst migraine pain in the year before starting galcanezumab. Linear and logistic regression identified years since the first symptom, worst migraine attack pain, premonitory symptoms, and income as significant predictors. RF explained more of the variance than multiple linear regression and introduced additional concepts to the prediction of MIBS, identifying well-being (WHO-5 total score), the WHO-5 item "cheerful and in good spirits," worry about exercise, and fear of missing social obligations as significant predictors. Socioeconomic status and income were also critical explanatory variables for interictal burden (IIB) based on regression modeling and RF. Still, income was the only variable significantly associated with IIB across regression and RF methods.

CONCLUSIONS

Interictal burden should be considered in the medical care of people with migraine. This additional burden is holistic, with psychosocial and socioeconomic elements in addition to residual symptoms. It is essential to consider this when assessing the impact of IIB.

摘要

背景

偏头痛的总体负担不仅包括头痛发作期,还贯穿于发作间期。发作间期症状及相关心理反应可能会对健康产生深远影响,并促使患者寻求治疗。

方法

对年龄≥18岁的参与者进行了一项横断面在线调查,其中250例为发作性偏头痛(EM)患者,250例为慢性偏头痛(CM)患者,每月偏头痛头痛天数≥4天。所有参与者均未使用过加卡尼单抗,或在调查完成前≤6个月开始使用。该研究评估了与偏头痛发作间期负担量表(MIBS-4)相关的因素,包括健康和幸福的社会决定因素。使用多元线性回归、逻辑回归和随机森林(RF)来探索MIBS-4的预测因素。

结果

大多数参与者(90%)为女性,平均(标准差)年龄为40.6(±12.0)岁,自首次偏头痛发作以来已有18.1(±12.7)年。在社会人口统计学方面,EM组和CM组相似。常见的合并症为焦虑症(45%)和抑郁症(44%)。59%的参与者报告有偏头痛家族史。MIBS-4与许多不同变量相关,包括幸福感、焦虑敏感性、收入、先兆症状以及开始使用加卡尼单抗前一年中最严重的偏头痛疼痛。线性和逻辑回归确定自首次出现症状以来的年数、最严重的偏头痛发作疼痛、先兆症状和收入为显著预测因素。RF比多元线性回归解释了更多的方差,并为MIBS的预测引入了其他概念,确定幸福感(WHO-5总分)、WHO-5项目“愉快且精神良好”、对运动的担忧以及对错过社交义务的恐惧为显著预测因素。基于回归模型和RF,社会经济地位和收入也是发作间期负担(IIB)的关键解释变量。然而,在回归和RF方法中,收入是唯一与IIB显著相关的变量。

结论

在偏头痛患者的医疗护理中应考虑发作间期负担。这种额外的负担是整体性的,除了残留症状外,还包括心理社会和社会经济因素。在评估IIB的影响时考虑到这一点至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bc/11658275/30a477589ab5/10194_2024_1927_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bc/11658275/db208b77e2c8/10194_2024_1927_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bc/11658275/30a477589ab5/10194_2024_1927_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bc/11658275/db208b77e2c8/10194_2024_1927_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4bc/11658275/30a477589ab5/10194_2024_1927_Fig2_HTML.jpg

相似文献

1
Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention.偏头痛患者在降钙素基因相关肽单克隆抗体预防开始时的发作间期负担。
J Headache Pain. 2024 Dec 18;25(1):220. doi: 10.1186/s10194-024-01927-8.
2
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study.加巴喷丁治疗后偏头痛发作间期负担的变化:一项 III 期随机、安慰剂对照研究的结果。
Headache. 2023 May;63(5):683-691. doi: 10.1111/head.14460. Epub 2023 Feb 16.
3
Measuring interictal burden among people affected by migraine: a descriptive survey study.测量偏头痛患者的发作间期负担:一项描述性调查研究。
J Headache Pain. 2022 Aug 8;23(1):97. doi: 10.1186/s10194-022-01467-z.
4
Predictors of migraine interictal burden: The hidden role of subjective memory complaints.偏头痛发作间期负担的预测因素:主观记忆障碍的潜在作用。
Headache. 2025 Jan;65(1):54-60. doi: 10.1111/head.14819. Epub 2024 Sep 13.
5
Interictal burden attributable to episodic headache: findings from the Eurolight project.发作性头痛所致发作间期负担:来自Eurolight项目的研究结果
J Headache Pain. 2016;17:9. doi: 10.1186/s10194-016-0599-8. Epub 2016 Feb 16.
6
Patient-reported outcomes related to migraine burden among patients treated with standard-of-care preventive medications or calcitonin gene-related monoclonal antibodies: a United States and Europe cross-sectional survey.在接受标准护理预防性药物或降钙素基因相关单克隆抗体治疗的患者中,与偏头痛负担相关的患者报告结局:一项美国和欧洲的横断面调查。
Curr Med Res Opin. 2024 Dec;40(12):2179-2190. doi: 10.1080/03007995.2024.2427884. Epub 2024 Nov 15.
7
[Interictal burden of migraine and its evaluations: a literature review].[偏头痛的发作间期负担及其评估:文献综述]
Rinsho Shinkeigaku. 2025 Jan 29;65(1):8-15. doi: 10.5692/clinicalneurol.cn-002016. Epub 2024 Dec 21.
8
Real-life experiences with galcanezumab and predictors for treatment response in Turkey.土耳其使用加奈珠单抗的真实体验及其治疗反应的预测因素。
BMC Neurol. 2023 Nov 23;23(1):418. doi: 10.1186/s12883-023-03467-1.
9
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review.加巴喷丁在偏头痛预防性治疗中的疗效和安全性:叙述性综述。
Adv Ther. 2020 May;37(5):2034-2049. doi: 10.1007/s12325-020-01319-9. Epub 2020 Apr 21.
10
Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.慢性和阵发性偏头痛的头痛影响:来自美国偏头痛患病率和预防研究的结果。
Headache. 2012 Jan;52(1):3-17. doi: 10.1111/j.1526-4610.2011.02046.x. Epub 2011 Nov 22.

引用本文的文献

1
What does a migraine aura look like?-A systematic review.偏头痛先兆是什么样的?一项系统综述。
J Headache Pain. 2025 Jul 1;26(1):149. doi: 10.1186/s10194-025-02080-6.
2
The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region.偏头痛的全球负担:按年龄、性别、国家和地区进行的30年趋势回顾与未来预测
Pain Ther. 2025 Feb;14(1):297-315. doi: 10.1007/s40122-024-00690-7. Epub 2024 Dec 11.

本文引用的文献

1
Patients' Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb).患者在开始使用降钙素基因相关肽(CGRP)单克隆抗体(mAb)预防偏头痛的漫长过程中的经历。
Pain Ther. 2024 Dec;13(6):1589-1615. doi: 10.1007/s40122-024-00652-z. Epub 2024 Sep 19.
2
Prevalence and burden of migraine in the United States: A systematic review.偏头痛在美国的流行率和负担:一项系统评价。
Headache. 2024 May;64(5):516-532. doi: 10.1111/head.14709. Epub 2024 May 3.
3
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
全球、区域和国家神经障碍疾病负担,1990-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Neurol. 2024 Apr;23(4):344-381. doi: 10.1016/S1474-4422(24)00038-3. Epub 2024 Mar 14.
4
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine.偏头痛对功能的影响:两项偏头痛患者生活质量定性研究的结果。
Headache. 2024 Feb;64(2):156-171. doi: 10.1111/head.14664. Epub 2024 Jan 18.
5
Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) Study.偏头痛相关耻辱感及其与残疾、发作间期负担和生活质量的关系:OVERCOME(美国)研究的结果。
Neurology. 2024 Feb 13;102(3):e208074. doi: 10.1212/WNL.0000000000208074. Epub 2024 Jan 17.
6
Societal and personal impact of migraine.偏头痛的社会和个人影响。
Handb Clin Neurol. 2023;198:23-29. doi: 10.1016/B978-0-12-823356-6.00015-9.
7
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study.加巴喷丁治疗后偏头痛发作间期负担的变化:一项 III 期随机、安慰剂对照研究的结果。
Headache. 2023 May;63(5):683-691. doi: 10.1111/head.14460. Epub 2023 Feb 16.
8
Global epidemiology of migraine and its implications for public health and health policy.偏头痛的全球流行病学及其对公共卫生和卫生政策的影响。
Nat Rev Neurol. 2023 Feb;19(2):109-117. doi: 10.1038/s41582-022-00763-1. Epub 2023 Jan 24.
9
The not so hidden impact of interictal burden in migraine: A narrative review.偏头痛发作间期负担的潜在影响:一项叙述性综述
Front Neurol. 2022 Nov 3;13:1032103. doi: 10.3389/fneur.2022.1032103. eCollection 2022.
10
The unique role of stigma in migraine-related disability and quality of life.污名化在偏头痛相关残疾和生活质量中的独特作用。
Headache. 2022 Nov;62(10):1354-1364. doi: 10.1111/head.14401. Epub 2022 Nov 2.